United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$258.13 USD
+2.99 (1.17%)
Updated May 2, 2024 04:00 PM ET
After-Market: $258.31 +0.18 (0.07%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $5.90 | 1.75% |
Earnings Summary
For their last quarter, United Therapeutics (UTHR) reported earnings of $6.17 per share, beating the Zacks Consensus Estimate of $5.63 per share. This reflects a positive earnings surprise of 9.59%. Look out for UTHR's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of $5.90 per share, reflecting a year-over-year increase of 12.6%.
Earnings History
Price & Consensus
Zacks News for UTHR
Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services